These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1156 related items for PubMed ID: 19334390

  • 1. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y, Karaoğlan I, Ciçek H, Karağoz ID, Sağlam M.
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [Abstract] [Full Text] [Related]

  • 2. [Comparison of hepatitis C virus (HCV) RNA and anti-HCV results and evaluation of the relationship between transaminase levels].
    Kaşifoğlu N, Us T, Akgün Y.
    Mikrobiyol Bul; 2007 Oct; 41(4):557-63. PubMed ID: 18173074
    [Abstract] [Full Text] [Related]

  • 3. Determination of the cut-off value of serum alanine aminotransferase in patients undergoing hemodialysis, to identify biochemical activity in patients with hepatitis C viremia.
    Lopes EP, Gouveia EC, Albuquerque AC, Sette LH, Mello LA, Moreira RC, Coelho MR.
    J Clin Virol; 2006 Mar; 35(3):298-302. PubMed ID: 16290052
    [Abstract] [Full Text] [Related]

  • 4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Mar; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 5. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0).
    Myrmel H, Navaratnam V, Asjø B.
    J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611
    [Abstract] [Full Text] [Related]

  • 6. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M.
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [Abstract] [Full Text] [Related]

  • 7. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, Keles H.
    Ren Fail; 2006 Oct; 28(8):729-35. PubMed ID: 17162434
    [Abstract] [Full Text] [Related]

  • 8. [Hepatitis C virus genotypes in a province of western Black-Sea region, Turkey].
    Aktaş E, Ogedey ED, Külah C, Beğendik Cömert F.
    Mikrobiyol Bul; 2010 Oct; 44(4):647-50. PubMed ID: 21063977
    [Abstract] [Full Text] [Related]

  • 9. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F.
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [Abstract] [Full Text] [Related]

  • 10. Is hepatitis C virus-RNA detection by nested polymerase chain reaction clinically relevant in hemodialysis patients?
    Dussol B, de Lamballerie X, Brunet P, Roubicek C, Chicheportiche C, Cantaloube JF, Biagini P, de Micco P, Berland Y.
    Clin Nephrol; 1996 Apr; 45(4):257-60. PubMed ID: 8861802
    [Abstract] [Full Text] [Related]

  • 11. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C, Hollò Z, Ciccone G, Ghisetti V, Barbui A, Fop F, Martina G, Forgnone F, Novo P, Thea A, Grill A, Marchiaro G.
    J Nephrol; 2000 Apr; 13(5):352-9. PubMed ID: 11063139
    [Abstract] [Full Text] [Related]

  • 12. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM.
    Cancer; 1998 Sep 15; 83(6):1224-30. PubMed ID: 9740089
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P, Medici MC, Casula F, Arcangeletti MC, De Conto F, Pinardi F, Calderaro A, Chezzi C, Dettori G.
    J Med Virol; 2004 Jul 15; 73(3):397-403. PubMed ID: 15170635
    [Abstract] [Full Text] [Related]

  • 14. [Low positive anti-HCV microparticle enzyme immunoassay results: do they predict hepatitis C virus infection?].
    Sayan M, Meriç M, Mutlu B, Celebi S, Willke A.
    Mikrobiyol Bul; 2006 Jul 15; 40(1-2):81-4. PubMed ID: 16775961
    [Abstract] [Full Text] [Related]

  • 15. Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.
    Carreño V, Pardo M, López-Alcorocho JM, Rodríguez-Iñigo E, Bartolomé J, Castillo I.
    J Infect Dis; 2006 Jul 01; 194(1):53-60. PubMed ID: 16741882
    [Abstract] [Full Text] [Related]

  • 16. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
    Huang WS, Lu SN, Wang JH, Lee CM, Tung HD, Chen TM, ChangChien CS.
    Hepatogastroenterology; 2005 Jul 01; 52(63):893-6. PubMed ID: 15966227
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of second-generation enzyme immunoassay for detection of hepatitis C virus infection among oncology patients.
    Macedo de Oliveira A, White KL, Beecham BD, Leschinsky DP, Foley BP, Dockter J, Giachetti C, Safranek TJ.
    J Clin Virol; 2006 Jan 01; 35(1):21-5. PubMed ID: 15921955
    [Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
    Couroucé AM, Bouchardeau F, Chauveau P, Le Marrec N, Girault A, Zins B, Naret C, Poignet JL.
    Nephrol Dial Transplant; 1995 Jan 01; 10(2):234-9. PubMed ID: 7538650
    [Abstract] [Full Text] [Related]

  • 19. [Hepatitis C virus screening: performances characteristics of a commercial automated chemiluminescent microparticle immunoassay (CMIA-ARCHITECT anti-HCV)].
    Petitjean Lecherbonnier J, Gouarin S, Dina J, Vabret A, Freymuth F.
    Pathol Biol (Paris); 2007 Dec 01; 55(10):512-20. PubMed ID: 17959324
    [Abstract] [Full Text] [Related]

  • 20. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied.
    Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P.
    Clin Nephrol; 2000 Aug 01; 54(2):151-6. PubMed ID: 10968693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.